Copper(I) bis(diphosphine) complexes as a basis for radiopharmaceuticals for positron emission tomography and targeted radiotherapy
Abstract
Copper(I) bis(diphosphine) complexes provide an excellent basis for development of short/medium-lived PET (position emission tomography) imaging and therapy agents containing copper radioisotopes, because of their extreme facility of synthesis and scope for derivatisation and bioconjugate formation.